Denali Therapeutics Inc.
Clinical trials sponsored by Denali Therapeutics Inc., explained in plain language.
-
New drug targets genetic root of Parkinson's in key trial
Disease control Recruiting nowThis study is testing an investigational drug called BIIB122 in people with Parkinson's disease caused by specific genetic changes in the LRRK2 gene. About 50 participants will receive either the drug or a placebo for 12 weeks to see if it's safe and how it affects certain biolog…
Phase: PHASE2 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New Alzheimer's drug enters human testing phase
Disease control Recruiting nowThis early-stage study is testing the safety and how the body processes DNL628, an experimental drug for early Alzheimer's disease. It will involve 68 participants with mild memory problems and confirmed Alzheimer's brain changes. Researchers will monitor side effects, measure dr…
Phase: PHASE1 • Sponsor: Denali Therapeutics Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC